Pfizer said in a statement that ReViral has a portfolio of antiviral drugs, including a follow-up RSV candidate targeting the viral N protein that ... its RSV vaccine RSVpreF for both adults ...

Pfizer's RSVpreF vaccine is in hot pursuit of GSK's shot, with results due to be reported very soon from the phase 3 RENOIR trial in older adults. It is also being developed for use in pregnant ...

Approved in August 2023, RSVpreF (Abrysvo) by Pfizer prevents lower respiratory infections caused by RSV and is also used for adults. Nirsevimab (beyfortus), approved in July 2023, provides targeted ...

Scroll through TikTok or Instagram and you’ll be inundated with protein-centric recipes. Maximizing protein is a huge trend right now on social media—and not just in the usual suspects ...

Best whey-protein powders Best collagen-protein powder Best plant-based protein powders All the other protein powders I’ve tried Protein powders can be found in thousands of formulations on tens ...

which may help mitigate disparities,” the authors write. Several authors disclosed ties to pharmaceutical companies, including Pfizer, which manufactures the RSVpreF vaccine, and Sanofi, which ...

Get Instant Summarized Text (Gist) The FDA has mandated safety labeling changes for the RSV vaccines Abrysvo and Arexvy to include warnings about the risk of Guillain-Barré syndrome (GBS ...

Persons with self-reported immunocompromising conditions were enrolled. Those reporting plans to receive adjuvanted RSV prefusion F (preF)3-AS01 E­ or nonadjuvanted RSVpreF were asked to provide blood ...

How much is Pfizer Inc stock worth? Invest with precise valuations. Get Report.